Glioblastoma Recurrence and the Role of O(6)-Methylguanine–DNA Methyltransferase Promoter Methylation

Tumor recurrence in glioblastoma multiforme (GBM) is often attributed to acquired resistance to the standard chemotherapeutic agent, temozolomide (TMZ). Promoter methylation of the DNA repair gene MGMT (O(6)-methylguanine–DNA methyltransferase) has been associated with sensitivity to TMZ, whereas in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JCO Clin Cancer Inform
Main Authors: Storey, Katie, Leder, Kevin, Hawkins-Daarud, Andrea, Swanson, Kristin, Ahmed, Atique U., Rockne, Russell C., Foo, Jasmine
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2019
Assuntos:
ORIGINAL REPORT
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6732255/
https://ncbi.nlm.nih.gov/pubmed/30758983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/CCI.18.00062
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares